Tag: molecular templates

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.

VIDEO — Life Science Update September 2018

With September officially behind us, the Investing News Network is taking a look back at some of the biggest news...

5 Top Weekly NASDAQ Biotech Stocks: Molecular Templates on Top

Molecular Templates, Galectin Therapeutic, Chiasma, ZioPharm Oncology and Caladrius Biosciences were last week's top gainers on the NASDAQ Biotechnology Index.

Molecular Templates Spikes on Big Pharma Deal

Molecular Templates announced on Wednesday that it will develop a protein-based oncology therapy with Takeda Pharmaceutical. Its share price rose...

Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy

Molecular Templates (Nasdaq:MTEM) announced an agreement with Takeda Pharmaceutical for the joint development of CD38-targeted engineered toxin bodies (ETBs) for...